Back

Nucleobase adduct-containing metabolites are MR1 ligands that stimulate self-reactive MR1T cells

Vacchini, A.; Chancellor, A.; Yang, Q.; Spagnuolo, J.; Joss, D.; Oyas, O.; Beshirova, A.; De Gregorio, C.; Pfeffer, M.; Stelling, J.; Häussinger, D.; Lepore, M.; Mori, L.; De Libero, G.

2022-08-26 immunology
10.1101/2022.08.26.505411 bioRxiv
Show abstract

MR1T lymphocytes are a recently identified population of T cells that recognize unknown self-antigens presented by the non-polymorphic MHC-I-related molecule, MR1. MR1T cells can kill tumor cells and modulate the functions of other immune cells with promising therapeutic applications. By integrating genetic, pharmacological and biochemical approaches we identified carbonyl stress and alterations of nucleobase metabolism in tumor target cells that promote recognition by MR1 T cells. We dissected these pathways and found that nucleobase adduct-containing metabolites are self-antigens stimulating MR1T cells. Several nucleobase adducts are presented by MR1 molecules and stimulate individual MR1T cells. Our data suggest that MR1T cells are surveyor of cellular metabolic alterations occurring in conditions of metabolic stress, such as cancer, and lay the groundwork for the development of novel HLA-unrestricted T cell-based therapies.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.